Figure 2From: Effectiveness of a proteoliposome-based vaccine against salmonid rickettsial septicaemia in Oncorhynchus mykissSafety and adverse effects vaccine evaluation. A Fulton’s condition factor, B Speilberg score. Values are represented as dot-plots with mean ± standard deviation. Vaccine 1: 10 µg total protein of P. salmonis proteoliposome emulsified with Montanide ISA 760 VG, Vaccine 2: 10 µg total protein of P. salmonis proteoliposome emulsified with ISA 763 A VG (Seppic, France).Back to article page